I am sure he is referring to secondary endpoints, all of which have not yet been scrubbed and disclosed. And I also expect these results to be positive and further confirm the safety and efficacy of Neutrolin which IMO will aid in a FDA go ahead on an NDA filing. Just my opinion. Good luck!